Teva-Sildenafil

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Teva-Sildenafil

Teva-Sildenafil is a generic drug preparation containing the active ingredient Sildenafil, which is classified as a Selective phosphodiesterase type 5 (PDE5) inhibitor. It is manufactured by Teva Canada, a prominent international generic company, and is designated as a Prescription-only medicine (POM).


Quick Facts

Property Description
Active ingredient Sildenafil Citrate (INN: Sildenafil)
Form Film-coated tablet
Pharmacological class Selective PDE5 inhibitor
General purpose Enhances blood flow via vasodilation
Origin Synthetic compound

What Type of Medicine is Teva-Sildenafil?

Teva-Sildenafil is a synthetic compound that functions by specifically targeting an enzyme critical for blood vessel regulation, placing it within the PDE5 inhibitor class. This classification is vital because it determines the drug’s core mechanism of effect—promoting the relaxation of muscle tissue surrounding blood vessels—and separates it from other cardiovascular or muscle-acting drugs. As a product from a recognized generic manufacturer, Teva-Sildenafil offers a pharmaceutically equivalent preparation of the Sildenafil molecule, an entity characterized by its action on vascular smooth muscle.


Composition and Pharmaceutical Form

The core chemical component of Teva-Sildenafil is Sildenafil Citrate, packaged as a single-ingredient product in a solid dosage form. The medicine is almost universally manufactured as an oral preparation, commonly appearing as a film-coated tablet intended for oral route of administration. The purpose of the surrounding inactive ingredients, or excipients, is solely to form the stable tablet structure and ensure the accurate delivery of the Sildenafil Citrate into the body.


What is the General Purpose of PDE5 Inhibitors?

The general purpose of Teva-Sildenafil stems from its ability to enhance blood flow through powerful, targeted vasodilation. By inhibiting PDE5, the drug helps prolong the action of naturally occurring compounds that signal the smooth muscle to relax, leading to the necessary widening of the blood vessels. This effect establishes the preparation's utility in treating conditions where improved circulation and vascular function are the primary therapeutic requirements, such as managing adult male vascular responsiveness.

What side effects are possible with Teva-Sildenafil?

Possible side effects and safety information

The official safety profile for Teva-Sildenafil classifies adverse reactions based on their frequency of occurrence, as documented in regulatory sources.

Frequency and Common Adverse Reactions

The most frequently documented adverse reactions are generally related to the drug’s vasodilatory properties. Reactions classified as Very Common or Common include Headache, Flushing (hot flushes), Dyspepsia (indigestion), and Nasal Congestion. Other common reactions include Dizziness, Back Pain, and Abnormal Vision, which is typically described as a transient color tinge or blurred sight. These common effects are grouped within specific system-organ classes, such as Nervous System Disorders and Vascular Disorders.


Serious Reactions and Safety Constraints

Regulatory labeling highlights specific, rare events that are considered clinically significant. These serious adverse reactions include Priapism (a prolonged erection lasting more than four hours) and sudden loss of vision due to Non-arteritic Anterior Ischemic Optic Neuropathy (NAION). Sudden decrease or loss of hearing has also been reported in temporal association with use.

Use is strictly defined by regulatory safety constraints. The medicine is contraindicated (prohibited) for concomitant use with any form of organic nitrate or nitric oxide donor due to the risk of severe hypotension. Furthermore, specific constraints apply to certain patient populations, including a contraindication for individuals with severe hepatic impairment.

Overdose and Emergency Response

Teva-Sildenafil Overdose and when to seek help

Documented overdose presentations in regulatory sources are characterized by the increased rate and severity of adverse events known at lower doses, observed following single doses up to 800 mg. These exaggerated clinical manifestations include intensified headache, pronounced flushing, dyspepsia, dizziness, and abnormal vision. Overdose risk is documented as potentially higher in patients with severe hepatic impairment or severe renal impairment due to their impaired drug clearance.

Required Emergency Actions

The official label mandates that patients seek emergency medical assistance immediately for specific, time-critical outcomes. These include a painful or non-painful erection (Priapism) lasting longer than four hours, as well as any instance of sudden loss of vision or a sudden decrease or loss of hearing. Contacting emergency medical services is required when an overdose is suspected.

The standard management of Sildenafil overdose is limited to symptomatic and supportive measures as clinically indicated. Regulatory sources confirm that no specific antidote is known, and due to the drug’s high plasma protein binding, renal dialysis is not expected to significantly accelerate clearance of the active ingredient.

Therapeutic Uses of Teva-Sildenafil

What Teva-Sildenafil Treats: Main Uses and Benefits

This medication is generally used to address two primary symptomatic conditions: erectile dysfunction (ED) and pulmonary arterial hypertension (PAH). It is utilized to help with symptoms related to systemic imbalance in these two distinct therapeutic domains.


Symptomatic Support Across Key Domains

Teva-Sildenafil is applied across domains where additional symptomatic support is needed. Specifically, it is relevant for managing symptoms that interfere with daily functioning in the case of ED, and assisting with symptom clusters that may become disruptive, such as breathlessness and fatigue, in PAH. The symptomatic benefit provides support that helps ease the overall symptom load.

The medication is commonly used to help with both erectile dysfunction and high blood pressure in the lungs. This indicates its use in situations involving certain distressing symptoms.

Quick Fact: Supports Symptom Management
Teva-Sildenafil assists with maintaining functional stability and supports patients during episodes of heightened discomfort related to its use in conditions characterized by periods of heightened symptoms.

Regulatory References

  1. NIH MedlinePlus overview on Sildenafil

Eligibility and Restrictions for Use

Teva-Sildenafil is officially approved for use in Adult Males (Erectile Dysfunction indication) and in Adults for Pulmonary Arterial Hypertension (PAH). While the PAH indication is also authorized for pediatric patients (ages 1–17), chronic use is officially not recommended for this age group due to safety concerns observed in clinical trials.


Absolute Restrictions (Contraindications)

The medicine is strictly forbidden for populations with known risks, including patients taking any form of organic nitrates or the guanylate cyclase stimulator riociguat. Contraindications also apply to individuals with a history of non-arteritic anterior ischaemic optic neuropathy (NAION), severe hypotension (blood pressure below 90/50 mmHg), or severe hepatic impairment. Furthermore, use is prohibited for men with severe cardiovascular disease for whom sexual activity is inadvisable, and in patients with a recent stroke or myocardial infarction (within six months).


Conditional Eligibility

Use is restricted and requires special consideration in patients with severe renal impairment (creatinine clearance below 30 mL/min), hepatic impairment, and in older adults (aged 65 years and above). Regulatory documents advise that a lower starting dose should be considered for these populations due to reduced drug clearance. Safety is not established for patients with bleeding disorders or active peptic ulceration.

What should I know about interactions with other medicines?

Teva-Sildenafil Interactions with other medicines and products

It is critical to inform a healthcare provider of all prescription, non-prescription, and herbal products currently being taken before starting Teva-Sildenafil (sildenafil). Co-administration of certain drugs can significantly affect how Teva-Sildenafil works and may increase the risk of serious side effects, particularly a sudden and dangerous drop in blood pressure.


Key Contraindicated Medications

Nitrates in any form are absolutely contraindicated. This includes medicines used to treat chest pain (angina) such as nitroglycerin, isosorbide dinitrate, or isosorbide mononitrate. The combination can cause a severe, life-threatening hypotensive episode. Teva-Sildenafil should also not be taken with recreational drugs known as 'poppers' (amyl nitrite/butyl nitrite).


Other Significant Interactions

Drug Class Example Medications Interaction Effect
Alpha-Blockers (for high blood pressure/prostate issues) Doxazosin, Tamsulosin Increased risk of low blood pressure (hypotension). Use with caution and only at the lowest dose of Teva-Sildenafil.
HIV Protease Inhibitors Ritonavir, Saquinavir These can increase sildenafil blood levels, potentially increasing side effects. A dose adjustment for Teva-Sildenafil is often necessary.
Certain Antifungals/Antibiotics Ketoconazole, Erythromycin Can increase sildenafil concentration, necessitating a dose reduction of Teva-Sildenafil.
Other Pulmonary Hypertension Treatments Riociguat The combination can cause dangerously low blood pressure and is contraindicated.

Mechanism of Action

How Teva-Sildenafil Works

The mechanism of Teva-Sildenafil is entirely peripheral and focuses on modulating a core signaling pathway involved in blood vessel dynamics.

Selective Inhibition of the PDE5 Enzyme

The drug acts as a selective inhibitor of the enzyme cGMP-specific phosphodiesterase type 5 (PDE5). This selective molecular interaction is the foundational step, blocking PDE5's ability to degrade the signaling molecule cyclic Guanosine Monophosphate (cGMP) within smooth muscle cells.

Augmentation of the NO/cGMP Pathway

By protecting cGMP from breakdown, Sildenafil maintains and augments the natural signal initiated by Nitric Oxide (NO) release, which is triggered by physiological input. This action leads to the relaxation signal being sustained, dependent on the prior activation of the NO pathway to be functional.

Modulation of Vascular Smooth Muscle Tone

The subsequent accumulation of cGMP directly causes relaxation of the smooth muscle surrounding the targeted arteries. This physiological change, known as vasodilation, results in an increase in blood flow and volume within the tissue, establishing the hydraulic conditions that are the result of the drug's mechanism.

Dosage and Administration Information

The use of Teva-Sildenafil oral tablets is restricted to adults and is governed by specific rules regarding dose, timing, and patient health status.

Administration Scope

Feature Official Guideline
Route of Administration Oral use only (tablet form).
Frequency Pattern As needed; maximum recommended dosing is once per day.
Timing in Relation to Meals Can be taken with or without food. Taking it with food may delay the onset of activity.
Preparation Requirements Tablets should be swallowed whole with water; no reconstitution or other preparation is specified.
Missed Dose Rules Not applicable, as the product is taken as needed prior to sexual activity.

Dosing Schedule and Special Conditions

Patient Group Recommended Starting Dose (Max Daily Dose)
Most Adult Patients 50 mg (Max 100 mg)
Elderly Patients (≥ 65 years) 25 mg should be considered; no mandated adjustment is required.
Severe Renal or Hepatic Impairment 25 mg should be considered.
Concomitant use with CYP3A4 Inhibitors 25 mg should be considered.
Concomitant use with Ritonavir Maximum recommended dose is 25 mg within a 48-hour period.

The standard dose is 50 mg, taken approximately one hour before sexual activity, though the timeframe for administration can range from 30 minutes to 4 hours beforehand. The effectiveness of the medication is conditional upon the presence of sexual stimulation.

Recent Clinical Evidence

Research evidence / Overview of studies for Teva-Sildenafil

This section summarizes the structure of clinical research conducted on Sildenafil, the active ingredient in Teva-Sildenafil, providing an overview of the types of studies performed, the outcomes researchers monitored, and the areas where information remains limited.


Evidence for Use in Erectile Dysfunction (ED)

Research examining Sildenafil for conditions marked by functional limitations, specifically Erectile Dysfunction (ED), has relied mainly on Randomized Controlled Trials (RCTs). These studies were applied in trials assessing short-term or episodic symptom patterns, often running for about 4 to 12 weeks. Researchers monitored patient-reported outcomes describing perceived discomfort and functional status using standardized tools like the International Index of Erectile Function (IIEF), as well as tracking the successful completion rate of sexual activity attempts. Research provides insight into short-term changes; however, long-term effects are not fully established by methodologically rigorous, blinded trials.


Evidence for Use in Pulmonary Arterial Hypertension (PAH)

The research on Sildenafil for conditions characterized by fluctuating or episodic manifestations, such as Pulmonary Arterial Hypertension (PAH), was evaluated in pivotal short-term (12- to 16-week) RCTs. Studies monitored outcomes related to systemic or functional imbalance. The primary functional measure was the change in 6-minute walk distance (6MWD), a test used in research settings to assess daily functioning or activity level. Data show patterns related to how functional status and exercise ability were observed in the study populations during the short-term study intervals. Comparative evidence is lacking for head-to-head assessments against other similar treatments for PAH.


What Remains Uncertain in the Research

Research provides context but not individual predictions; the evidence highlights what is known and what is still uncertain. Key limitations include the fact that results apply only to the populations studied. There is limited information for long-term outcomes for both indications, as the most methodologically rigorous trials were short-term. Data for certain groups, particularly those with complex or rare comorbidities, remain insufficient.

Frequently Asked Questions (FAQ)

Common questions about Teva-Sildenafil (FAQ)

Q: How fast does Teva-Sildenafil usually start to work?

Maximum concentration of the drug in the blood is typically reached within 30 to 120 minutes, with the median time being one hour, when taken without food. This absorption profile provides context for when effects may begin to be noted. Official information states that the effects are conditional upon the presence of sexual stimulation.

Q: How long does the effect of Teva-Sildenafil last?

Regulatory documents describe that the effects have been observed to last for up to 4 hours. Official information states that the response may lessen toward the end of this period when compared to the effect observed at two hours after administration.

Q: Can eating a high-fat meal affect how quickly Teva-Sildenafil works?

Official documentation states that consuming a high-fat meal can slow down the rate at which the body absorbs the medicine. This reduction in the absorption rate is associated with a delay in the time it takes for the drug to reach its maximum concentration in the blood by approximately one hour.

Q: Is it possible to experience vision changes, such as a blue tint, while taking Teva-Sildenafil?

Abnormal vision is listed in official safety profiles as a common side effect of sildenafil. This effect is typically described as a transient color tinge, such as a blue tint, or blurred sight.

Q: What happens if Teva-Sildenafil is taken with grapefruit products?

Grapefruit juice is reported to increase the blood levels of sildenafil because it can inhibit certain enzymes involved in the drug's metabolism. This interaction may potentially lead to higher levels of the medication in the body, which is associated with an increased potential for side effects.

Q: Are there any reported long-term effects associated with using Teva-Sildenafil for many years?

Official reviews indicate that the most rigorous clinical trials conducted on sildenafil were short-term studies. For this reason, official product information notes that long-term outcomes associated with using the medicine are not fully established by the most methodologically rigorous blinded trials.

Q: What does available research say about the effectiveness of sildenafil for erectile dysfunction?

Clinical research, primarily based on randomized controlled trials, indicates that sildenafil administration improves erectile function compared to a placebo. This improvement in function is observed when sexual stimulation is present.

Q: Is Teva-Sildenafil safe for people with certain eye conditions, like retinitis pigmentosa?

Regulatory documents state that the use of Teva-Sildenafil in individuals with known retinitis pigmentosa is not recommended. This is due to the lack of controlled clinical data regarding use or effectiveness of the medicine in this specific population.

Q: Is Teva-Sildenafil considered a hormonal treatment?

No. Teva-Sildenafil is officially classified as a Selective Phosphodiesterase-5 (PDE5) inhibitor. It is a synthetic compound that works by regulating an enzyme involved in blood vessel dynamics, not by modulating hormones.

Q: How often can Teva-Sildenafil generally be taken?

According to the official product information for the erectile dysfunction indication, the maximum recommended frequency for taking the medicine is once per day.

Q: Does taking Teva-Sildenafil prevent pregnancy or protect against STIs?

The medicine is not indicated for use as a form of contraception. Furthermore, official information explicitly states that Teva-Sildenafil does not protect against sexually transmitted infections (STIs).

Q: Is Teva-Sildenafil something that can cause a spontaneous erection without arousal?

The medicine's mechanism of effect is entirely dependent upon the natural signal initiated by sexual stimulation. Official information states that the effectiveness of the drug is conditional upon the presence of sexual stimulation to start the necessary physiological pathway.

Q: What are the signs of a severe or serious adverse reaction to Teva-Sildenafil?

Signs of serious reactions include a prolonged erection lasting longer than four hours (priapism), sudden loss of vision in one or both eyes, or sudden decrease or loss of hearing. Official documents describe that immediate medical attention is required if any of these signs occur.

Q: Does Teva-Sildenafil interact with common blood pressure medicines like alpha-blockers?

Official documents warn that combining sildenafil with certain blood pressure medicines, such as alpha-blockers, can increase the risk of developing low blood pressure (hypotension). This warning exists due to the potential for a severe drop in blood pressure when these medications are combined.

Q: Can women use Teva-Sildenafil for conditions like pulmonary arterial hypertension (PAH)?

Yes. The active ingredient sildenafil is approved and used to treat Pulmonary Arterial Hypertension (PAH) in both women and men.

Q: How does the body generally process and eliminate Teva-Sildenafil (pharmacokinetics)?

According to official pharmacokinetic documents, the medicine is primarily broken down through metabolism by enzymes in the liver. The resulting components are then mostly eliminated from the body in the feces, with a smaller amount excreted in the urine.

Q: Does Teva-Sildenafil have any reported effect on fertility?

Studies in animals have been conducted and reported no evidence of impaired fertility. Official documents note that the medicine is not approved for use in women undergoing fertility treatments.

Q: Is it normal for a person to experience indigestion or heartburn after taking Teva-Sildenafil?

Dyspepsia, which is the medical term for indigestion, is officially listed in regulatory documents as a common side effect of sildenafil. Heartburn is often associated with this common adverse effect.

Q: Why do official guidelines warn against taking Teva-Sildenafil with other ED medicines?

Official warnings advise against the combination of sildenafil with other PDE-5 inhibitors (like other ED medicines). This is because the safety and efficacy of combining these similar medications have not been studied in clinical research.

How should Teva-Sildenafil be stored and disposed of?

How to Store and Dispose of Teva-Sildenafil?

Official Storage Conditions

Storage requirements for Teva-Sildenafil film-coated tablets are defined by regulatory labeling to maintain stability. The medicine must always be kept out of the sight and reach of children.

Temperature conditions generally require storage between 15°C and 30°C (room temperature), and the product must not freeze. It is necessary to store the tablets in the original container to protect them from light and ensure they are not used after the expiry date.

Disposal Instructions

Official guidance requires that unused or expired tablets not be thrown away via wastewater or household waste. This is necessary for environmental protection. Patients are instructed to ask their pharmacist for the proper method of disposal for unused medicines.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Teva-Sildenafil found in:

A-Z Index: